Latest filing published 14 Aug 2026 for 10x Genomics, Inc., €113k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Sarah A Polonius-Teichmann: trading record in brief
Sarah A Polonius-Teichmann appears in our data through filings on 10x Genomics, Inc. shares, published by SEC (Form 4). In total, 2 filings cover trades dated from 13 August 2026 to 14 August 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 14 August 2026: a transaction of €113k, in 10x Genomics, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Sarah A Polonius-Teichmann
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,273 shares@ US$57.15CommonSEC144:0001950047-26-008153
- 5,278 shares@ US$57.290.0040% mcap100.0% of flowCommonSEC144:0001950047-26-008060
2 of 2 declarations
